Reply to: Neuroclinical Assessment of Addiction Needs to Incorporate Decision-Making Measures and Ecological Validity

Affiliations

• ¹ Office of the Clinical Director, Bethesda, Maryland. Electronic address: laura.kwako@nih.gov.
• ² Section on Brain Electrophysiology and Imaging, Division of Intramural Clinical and Biological Research, Bethesda, Maryland.
• ³ Division of Medications Development, Bethesda, Maryland.
• ⁴ Office of the Director, Bethesda, Maryland.
• ⁵ Office of the Clinical Director, Bethesda, Maryland; Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.